 | • レポートコード：D0GIR-02223 • 出版社/出版日：GlobalInfoResearch / 2020年9月23日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、128ページ • 納品方法：Eメール • 産業分類：医療、製薬、バイオ |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、ペプチド治療薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。ペプチド治療薬の種類別市場規模（注射、経口、その他）、用途別市場規模（がん、代謝障害、中枢神経系、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Sanofi、Ipsen、Takeda、Eli Lilly、AstraZeneca、Novo Nordisk、Allergan、Novartis、Teva、AbbVie、Lonza、Ferring、Tarix Pharmaceuticals、Merck、JNJ ・地域別グローバル市場分析 2015年-2020年 ・ペプチド治療薬の北米市場（アメリカ、カナダ、メキシコ） ・ペプチド治療薬のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・ペプチド治療薬のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・ペプチド治療薬の南米市場（ブラジル、アルゼンチン） ・ペプチド治療薬の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：注射、経口、その他 ・用途別分析：がん、代謝障害、中枢神経系、その他 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The Peptide Therapeutics Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The global Peptide Therapeutics Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx%% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
Market segmentation
Peptide Therapeutics Drugs market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Peptide Therapeutics Drugs market has been segmented into:
Injection
Oral
Other
By Application, Peptide Therapeutics Drugs has been segmented into:
Cancer
Metabolic Disorders
Central Nervous System
Other
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Peptide Therapeutics Drugs market presented in the report. This section sheds light on the sales growth of different regional and country-level Peptide Therapeutics Drugs markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Peptide Therapeutics Drugs market.
The report offers in-depth assessment of the growth and other aspects of the Peptide Therapeutics Drugs market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Peptide Therapeutics Drugs Market Share Analysis
Peptide Therapeutics Drugs competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Peptide Therapeutics Drugs sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Peptide Therapeutics Drugs sales, revenue and market share for each player covered in this report.
The major players covered in Peptide Therapeutics Drugs are:
Sanofi
Ipsen
Takeda
Eli Lilly
AstraZeneca
Novo Nordisk
Allergan
Novartis
Teva
AbbVie
Lonza
Ferring
Tarix Pharmaceuticals
Merck
JNJ
Among other players domestic and global, Peptide Therapeutics Drugs market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
1 Peptide Therapeutics Drugs Market Overview
1.1 Product Overview and Scope of Peptide Therapeutics Drugs
1.2 Classification of Peptide Therapeutics Drugs by Type
1.2.1 Global Peptide Therapeutics Drugs Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Peptide Therapeutics Drugs Revenue Market Share by Type in 2019
1.2.3 Injection
1.2.4 Oral
1.2.5 Other
1.3 Global Peptide Therapeutics Drugs Market by Application
1.3.1 Overview: Global Peptide Therapeutics Drugs Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Cancer
1.3.3 Metabolic Disorders
1.3.4 Central Nervous System
1.3.5 Other
1.4 Global Peptide Therapeutics Drugs Market by Regions
1.4.1 Global Peptide Therapeutics Drugs Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Peptide Therapeutics Drugs (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Peptide Therapeutics Drugs Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Peptide Therapeutics Drugs Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Peptide Therapeutics Drugs Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Peptide Therapeutics Drugs Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Peptide Therapeutics Drugs Status and Prospect (2015-2025)
2 Company Profiles
2.1 Sanofi
2.1.1 Sanofi Details
2.1.2 Sanofi Major Business
2.1.3 Sanofi SWOT Analysis
2.1.4 Sanofi Product and Services
2.1.5 Sanofi Peptide Therapeutics Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.2 Ipsen
2.2.1 Ipsen Details
2.2.2 Ipsen Major Business
2.2.3 Ipsen SWOT Analysis
2.2.4 Ipsen Product and Services
2.2.5 Ipsen Peptide Therapeutics Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.3 Takeda
2.3.1 Takeda Details
2.3.2 Takeda Major Business
2.3.3 Takeda SWOT Analysis
2.3.4 Takeda Product and Services
2.3.5 Takeda Peptide Therapeutics Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.4 Eli Lilly
2.4.1 Eli Lilly Details
2.4.2 Eli Lilly Major Business
2.4.3 Eli Lilly SWOT Analysis
2.4.4 Eli Lilly Product and Services
2.4.5 Eli Lilly Peptide Therapeutics Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.5 AstraZeneca
2.5.1 AstraZeneca Details
2.5.2 AstraZeneca Major Business
2.5.3 AstraZeneca SWOT Analysis
2.5.4 AstraZeneca Product and Services
2.5.5 AstraZeneca Peptide Therapeutics Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.6 Novo Nordisk
2.6.1 Novo Nordisk Details
2.6.2 Novo Nordisk Major Business
2.6.3 Novo Nordisk Product and Services
2.6.4 Novo Nordisk Peptide Therapeutics Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.7 Allergan
2.7.1 Allergan Details
2.7.2 Allergan Major Business
2.7.3 Allergan Product and Services
2.7.4 Allergan Peptide Therapeutics Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.8 Novartis
2.8.1 Novartis Details
2.8.2 Novartis Major Business
2.8.3 Novartis Product and Services
2.8.4 Novartis Peptide Therapeutics Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.9 Teva
2.9.1 Teva Details
2.9.2 Teva Major Business
2.9.3 Teva Product and Services
2.9.4 Teva Peptide Therapeutics Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.10 AbbVie
2.10.1 AbbVie Details
2.10.2 AbbVie Major Business
2.10.3 AbbVie Product and Services
2.10.4 AbbVie Peptide Therapeutics Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.11 Lonza
2.11.1 Lonza Details
2.11.2 Lonza Major Business
2.11.3 Lonza Product and Services
2.11.4 Lonza Peptide Therapeutics Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.12 Ferring
2.12.1 Ferring Details
2.12.2 Ferring Major Business
2.12.3 Ferring Product and Services
2.12.4 Ferring Peptide Therapeutics Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.13 Tarix Pharmaceuticals
2.13.1 Tarix Pharmaceuticals Details
2.13.2 Tarix Pharmaceuticals Major Business
2.13.3 Tarix Pharmaceuticals Product and Services
2.13.4 Tarix Pharmaceuticals Peptide Therapeutics Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.14 Merck
2.14.1 Merck Details
2.14.2 Merck Major Business
2.14.3 Merck Product and Services
2.14.4 Merck Peptide Therapeutics Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.15 JNJ
2.15.1 JNJ Details
2.15.2 JNJ Major Business
2.15.3 JNJ Product and Services
2.15.4 JNJ Peptide Therapeutics Drugs Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Peptide Therapeutics Drugs Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Peptide Therapeutics Drugs Players Market Share
3.2.2 Top 10 Peptide Therapeutics Drugs Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Peptide Therapeutics Drugs Revenue and Market Share by Regions
4.2 North America Peptide Therapeutics Drugs Revenue and Growth Rate (2015-2020)
4.3 Europe Peptide Therapeutics Drugs Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Peptide Therapeutics Drugs Revenue and Growth Rate (2015-2020)
4.5 South America Peptide Therapeutics Drugs Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Peptide Therapeutics Drugs Revenue and Growth Rate (2015-2020)
5 North America Peptide Therapeutics Drugs Revenue by Countries
5.1 North America Peptide Therapeutics Drugs Revenue by Countries (2015-2020)
5.2 USA Peptide Therapeutics Drugs Revenue and Growth Rate (2015-2020)
5.3 Canada Peptide Therapeutics Drugs Revenue and Growth Rate (2015-2020)
5.4 Mexico Peptide Therapeutics Drugs Revenue and Growth Rate (2015-2020)
6 Europe Peptide Therapeutics Drugs Revenue by Countries
6.1 Europe Peptide Therapeutics Drugs Revenue by Countries (2015-2020)
6.2 Germany Peptide Therapeutics Drugs Revenue and Growth Rate (2015-2020)
6.3 UK Peptide Therapeutics Drugs Revenue and Growth Rate (2015-2020)
6.4 France Peptide Therapeutics Drugs Revenue and Growth Rate (2015-2020)
6.5 Russia Peptide Therapeutics Drugs Revenue and Growth Rate (2015-2020)
6.6 Italy Peptide Therapeutics Drugs Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Peptide Therapeutics Drugs Revenue by Countries
7.1 Asia-Pacific Peptide Therapeutics Drugs Revenue by Countries (2015-2020)
7.2 China Peptide Therapeutics Drugs Revenue and Growth Rate (2015-2020)
7.3 Japan Peptide Therapeutics Drugs Revenue and Growth Rate (2015-2020)
7.4 Korea Peptide Therapeutics Drugs Revenue and Growth Rate (2015-2020)
7.5 India Peptide Therapeutics Drugs Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Peptide Therapeutics Drugs Revenue and Growth Rate (2015-2020)
8 South America Peptide Therapeutics Drugs Revenue by Countries
8.1 South America Peptide Therapeutics Drugs Revenue by Countries (2015-2020)
8.2 Brazil Peptide Therapeutics Drugs Revenue and Growth Rate (2015-2020)
8.3 Argentina Peptide Therapeutics Drugs Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Peptide Therapeutics Drugs by Countries
9.1 Middle East & Africa Peptide Therapeutics Drugs Revenue by Countries (2015-2020)
9.2 Saudi Arabia Peptide Therapeutics Drugs Revenue and Growth Rate (2015-2020)
9.3 UAE Peptide Therapeutics Drugs Revenue and Growth Rate (2015-2020)
9.4 Egypt Peptide Therapeutics Drugs Revenue and Growth Rate (2015-2020)
9.5 South Africa Peptide Therapeutics Drugs Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Peptide Therapeutics Drugs Revenue and Market Share by Type (2015-2020)
10.2 Global Peptide Therapeutics Drugs Market Forecast by Type (2019-2024)
10.3 Injection Revenue Growth Rate (2015-2025)
10.4 Oral Revenue Growth Rate (2015-2025)
10.5 Other Revenue Growth Rate (2015-2025)
11 Global Peptide Therapeutics Drugs Market Segment by Application
11.1 Global Peptide Therapeutics Drugs Revenue Market Share by Application (2015-2020)
11.2 Peptide Therapeutics Drugs Market Forecast by Application (2019-2024)
11.3 Cancer Revenue Growth (2015-2020)
11.4 Metabolic Disorders Revenue Growth (2015-2020)
11.5 Central Nervous System Revenue Growth (2015-2020)
11.6 Other Revenue Growth (2015-2020)
12 Global Peptide Therapeutics Drugs Market Size Forecast (2021-2025)
12.1 Global Peptide Therapeutics Drugs Market Size Forecast (2021-2025)
12.2 Global Peptide Therapeutics Drugs Market Forecast by Regions (2021-2025)
12.3 North America Peptide Therapeutics Drugs Revenue Market Forecast (2021-2025)
12.4 Europe Peptide Therapeutics Drugs Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Peptide Therapeutics Drugs Revenue Market Forecast (2021-2025)
12.6 South America Peptide Therapeutics Drugs Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Peptide Therapeutics Drugs Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Peptide Therapeutics Drugs Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Peptide Therapeutics Drugs by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Peptide Therapeutics Drugs Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Peptide Therapeutics Drugs Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global Peptide Therapeutics Drugs Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. Sanofi Corporate Information, Location and Competitors
Table 7. Sanofi Peptide Therapeutics Drugs Major Business
Table 8. Sanofi Peptide Therapeutics Drugs Total Revenue (USD Million) (2017-2018)
Table 9. Sanofi SWOT Analysis
Table 10. Sanofi Peptide Therapeutics Drugs Product and Solutions
Table 11. Sanofi Peptide Therapeutics Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. Ipsen Corporate Information, Location and Competitors
Table 13. Ipsen Peptide Therapeutics Drugs Major Business
Table 14. Ipsen Peptide Therapeutics Drugs Total Revenue (USD Million) (2018-2019)
Table 15. Ipsen SWOT Analysis
Table 16. Ipsen Peptide Therapeutics Drugs Product and Solutions
Table 17. Ipsen Peptide Therapeutics Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. Takeda Corporate Information, Location and Competitors
Table 19. Takeda Peptide Therapeutics Drugs Major Business
Table 20. Takeda Peptide Therapeutics Drugs Total Revenue (USD Million) (2017-2018)
Table 21. Takeda SWOT Analysis
Table 22. Takeda Peptide Therapeutics Drugs Product and Solutions
Table 23. Takeda Peptide Therapeutics Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 24. Eli Lilly Corporate Information, Location and Competitors
Table 25. Eli Lilly Peptide Therapeutics Drugs Major Business
Table 26. Eli Lilly Peptide Therapeutics Drugs Total Revenue (USD Million) (2017-2018)
Table 27. Eli Lilly SWOT Analysis
Table 28. Eli Lilly Peptide Therapeutics Drugs Product and Solutions
Table 29. Eli Lilly Peptide Therapeutics Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 30. AstraZeneca Corporate Information, Location and Competitors
Table 31. AstraZeneca Peptide Therapeutics Drugs Major Business
Table 32. AstraZeneca Peptide Therapeutics Drugs Total Revenue (USD Million) (2017-2018)
Table 33. AstraZeneca SWOT Analysis
Table 34. AstraZeneca Peptide Therapeutics Drugs Product and Solutions
Table 35. AstraZeneca Peptide Therapeutics Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 36. Novo Nordisk Corporate Information, Location and Competitors
Table 37. Novo Nordisk Peptide Therapeutics Drugs Major Business
Table 38. Novo Nordisk Peptide Therapeutics Drugs Total Revenue (USD Million) (2017-2018)
Table 39. Novo Nordisk SWOT Analysis
Table 40. Novo Nordisk Peptide Therapeutics Drugs Product and Solutions
Table 41. Novo Nordisk Peptide Therapeutics Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 42. Allergan Corporate Information, Location and Competitors
Table 43. Allergan Peptide Therapeutics Drugs Major Business
Table 44. Allergan Peptide Therapeutics Drugs Total Revenue (USD Million) (2017-2018)
Table 45. Allergan SWOT Analysis
Table 46. Allergan Peptide Therapeutics Drugs Product and Solutions
Table 47. Allergan Peptide Therapeutics Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 48. Novartis Corporate Information, Location and Competitors
Table 49. Novartis Peptide Therapeutics Drugs Major Business
Table 50. Novartis Peptide Therapeutics Drugs Total Revenue (USD Million) (2017-2018)
Table 51. Novartis SWOT Analysis
Table 52. Novartis Peptide Therapeutics Drugs Product and Solutions
Table 53. Novartis Peptide Therapeutics Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 54. Teva Corporate Information, Location and Competitors
Table 55. Teva Peptide Therapeutics Drugs Major Business
Table 56. Teva Peptide Therapeutics Drugs Total Revenue (USD Million) (2017-2018)
Table 57. Teva SWOT Analysis
Table 58. Teva Peptide Therapeutics Drugs Product and Solutions
Table 59. Teva Peptide Therapeutics Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 60. AbbVie Corporate Information, Location and Competitors
Table 61. AbbVie Peptide Therapeutics Drugs Major Business
Table 62. AbbVie Peptide Therapeutics Drugs Total Revenue (USD Million) (2017-2018)
Table 63. AbbVie SWOT Analysis
Table 64. AbbVie Peptide Therapeutics Drugs Product and Solutions
Table 65. AbbVie Peptide Therapeutics Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 66. Lonza Corporate Information, Location and Competitors
Table 67. Lonza Peptide Therapeutics Drugs Major Business
Table 68. Lonza Peptide Therapeutics Drugs Total Revenue (USD Million) (2017-2018)
Table 69. Lonza SWOT Analysis
Table 70. Lonza Peptide Therapeutics Drugs Product and Solutions
Table 71. Lonza Peptide Therapeutics Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 72. Ferring Corporate Information, Location and Competitors
Table 73. Ferring Peptide Therapeutics Drugs Major Business
Table 74. Ferring Peptide Therapeutics Drugs Total Revenue (USD Million) (2017-2018)
Table 75. Ferring SWOT Analysis
Table 76. Ferring Peptide Therapeutics Drugs Product and Solutions
Table 77. Ferring Peptide Therapeutics Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 78. Tarix Pharmaceuticals Corporate Information, Location and Competitors
Table 79. Tarix Pharmaceuticals Peptide Therapeutics Drugs Major Business
Table 80. Tarix Pharmaceuticals Peptide Therapeutics Drugs Total Revenue (USD Million) (2017-2018)
Table 81. Tarix Pharmaceuticals SWOT Analysis
Table 82. Tarix Pharmaceuticals Peptide Therapeutics Drugs Product and Solutions
Table 83. Tarix Pharmaceuticals Peptide Therapeutics Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 84. Merck Corporate Information, Location and Competitors
Table 85. Merck Peptide Therapeutics Drugs Major Business
Table 86. Merck Peptide Therapeutics Drugs Total Revenue (USD Million) (2017-2018)
Table 87. Merck SWOT Analysis
Table 88. Merck Peptide Therapeutics Drugs Product and Solutions
Table 89. Merck Peptide Therapeutics Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 90. JNJ Corporate Information, Location and Competitors
Table 91. JNJ Peptide Therapeutics Drugs Major Business
Table 92. JNJ Peptide Therapeutics Drugs Total Revenue (USD Million) (2017-2018)
Table 93. JNJ SWOT Analysis
Table 94. JNJ Peptide Therapeutics Drugs Product and Solutions
Table 95. JNJ Peptide Therapeutics Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 96. Global Peptide Therapeutics Drugs Revenue (Million USD) by Players (2015-2020)
Table 97. Global Peptide Therapeutics Drugs Revenue Share by Players (2015-2020)
Table 98. Global Peptide Therapeutics Drugs Revenue (Million USD) by Regions (2015-2020)
Table 99. Global Peptide Therapeutics Drugs Revenue Market Share by Regions (2015-2020)
Table 100. North America Peptide Therapeutics Drugs Revenue by Countries (2015-2020)
Table 101. North America Peptide Therapeutics Drugs Revenue Market Share by Countries (2015-2020)
Table 102. Europe Peptide Therapeutics Drugs Revenue (Million USD) by Countries (2015-2020)
Table 103. Asia-Pacific Peptide Therapeutics Drugs Revenue (Million USD) by Countries (2015-2020)
Table 104. South America Peptide Therapeutics Drugs Revenue by Countries (2015-2020)
Table 105. South America Peptide Therapeutics Drugs Revenue Market Share by Countries (2015-2020)
Table 106. Middle East and Africa Peptide Therapeutics Drugs Revenue (Million USD) by Countries (2015-2020)
Table 107. Middle East and Africa Peptide Therapeutics Drugs Revenue Market Share by Countries (2015-2020)
Table 108. Global Peptide Therapeutics Drugs Revenue (Million USD) by Type (2015-2020)
Table 109. Global Peptide Therapeutics Drugs Revenue Share by Type (2015-2020)
Table 110. Global Peptide Therapeutics Drugs Revenue Forecast by Type (2021-2025)
Table 111. Global Peptide Therapeutics Drugs Revenue by Application (2015-2020)
Table 112. Global Peptide Therapeutics Drugs Revenue Share by Application (2015-2020)
Table 113. Global Peptide Therapeutics Drugs Revenue Forecast by Application (2021-2025)
Table 114. Global Peptide Therapeutics Drugs Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Peptide Therapeutics Drugs Picture
Figure 2. Global Peptide Therapeutics Drugs Revenue Market Share by Type in 2019
Figure 3. Injection Picture
Figure 4. Oral Picture
Figure 5. Other Picture
Figure 6. Peptide Therapeutics Drugs Revenue Market Share by Application in 2019
Figure 7. Cancer Picture
Figure 8. Metabolic Disorders Picture
Figure 9. Central Nervous System Picture
Figure 10. Other Picture
Figure 11. Global Peptide Therapeutics Drugs Revenue (USD Million) and Growth Rate (2015-2025)
Figure 12. North America Peptide Therapeutics Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Europe Peptide Therapeutics Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Asia-Pacific Peptide Therapeutics Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. South America Peptide Therapeutics Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Middle East and Africa Peptide Therapeutics Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Peptide Therapeutics Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Peptide Therapeutics Drugs Revenue Share by Players in 2019
Figure 19. Global Top 5 Players Peptide Therapeutics Drugs Revenue Market Share in 2019
Figure 20. Global Top 10 Players Peptide Therapeutics Drugs Revenue Market Share in 2019
Figure 21. Key Players Market Share Trend
Figure 22. Global Peptide Therapeutics Drugs Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 23. Global Peptide Therapeutics Drugs Revenue Market Share by Regions (2015-2020)
Figure 24. Global Peptide Therapeutics Drugs Revenue Market Share by Regions in 2018
Figure 25. North America Peptide Therapeutics Drugs Revenue and Growth Rate (2015-2020)
Figure 26. Europe Peptide Therapeutics Drugs Revenue and Growth Rate (2015-2020)
Figure 27. Asia-Pacific Peptide Therapeutics Drugs Revenue and Growth Rate (2015-2020)
Figure 28. South America Peptide Therapeutics Drugs Revenue and Growth Rate (2015-2020)
Figure 29. Middle East and Africa Peptide Therapeutics Drugs Revenue and Growth Rate (2015-2020)
Figure 30. North America Peptide Therapeutics Drugs Revenue Market Share by Countries (2015-2020)
Figure 31. North America Peptide Therapeutics Drugs Revenue Market Share by Countries in 2019
Figure 32. USA Peptide Therapeutics Drugs Revenue and Growth Rate (2015-2020)
Figure 33. Canada Peptide Therapeutics Drugs Revenue and Growth Rate (2015-2020)
Figure 34. Mexico Peptide Therapeutics Drugs Revenue and Growth Rate (2015-2020)
Figure 35. Europe Peptide Therapeutics Drugs Revenue Market Share by Countries (2015-2020)
Figure 36. Europe Peptide Therapeutics Drugs Revenue Market Share by Countries in 2019
Figure 37. Germany Peptide Therapeutics Drugs Revenue and Growth Rate (2015-2020)
Figure 38. UK Peptide Therapeutics Drugs Revenue and Growth Rate (2015-2020)
Figure 39. France Peptide Therapeutics Drugs Revenue and Growth Rate (2015-2020)
Figure 40. Russia Peptide Therapeutics Drugs Revenue and Growth Rate (2015-2020)
Figure 41. Italy Peptide Therapeutics Drugs Revenue and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Peptide Therapeutics Drugs Revenue Market Share by Countries (2015-2020)
Figure 43. Asia-Pacific Peptide Therapeutics Drugs Revenue Market Share by Countries in 2019
Figure 44. China Peptide Therapeutics Drugs Revenue and Growth Rate (2015-2020)
Figure 45. Japan Peptide Therapeutics Drugs Revenue and Growth Rate (2015-2020)
Figure 46. Korea Peptide Therapeutics Drugs Revenue and Growth Rate (2015-2020)
Figure 47. India Peptide Therapeutics Drugs Revenue and Growth Rate (2015-2020)
Figure 48. Southeast Asia Peptide Therapeutics Drugs Revenue and Growth Rate (2015-2020)
Figure 49. South America Peptide Therapeutics Drugs Revenue Market Share by Countries (2015-2020)
Figure 50. South America Peptide Therapeutics Drugs Revenue Market Share by Countries in 2019
Figure 51. Brazil Peptide Therapeutics Drugs Revenue and Growth Rate (2015-2020)
Figure 52. Argentina Peptide Therapeutics Drugs Revenue and Growth Rate (2015-2020)
Figure 53. Middle East and Africa Peptide Therapeutics Drugs Revenue Market Share by Countries (2015-2020)
Figure 54. Middle East and Africa Peptide Therapeutics Drugs Revenue Market Share by Countries in 2019
Figure 55. Saudi Arabia Peptide Therapeutics Drugs Revenue and Growth Rate (2015-2020)
Figure 56. UAE Peptide Therapeutics Drugs Revenue and Growth Rate (2015-2020)
Figure 57. Egypt Peptide Therapeutics Drugs Revenue and Growth Rate (2015-2020)
Figure 58. South Africa Peptide Therapeutics Drugs Revenue and Growth Rate (2015-2020)
Figure 59. Global Peptide Therapeutics Drugs Revenue Share by Type (2015-2020)
Figure 60. Global Peptide Therapeutics Drugs Revenue Share by Type in 2019
Figure 61. Global Peptide Therapeutics Drugs Market Share Forecast by Type (2021-2025)
Figure 62. Global Injection Revenue Growth Rate (2015-2020)
Figure 63. Global Oral Revenue Growth Rate (2015-2020)
Figure 64. Global Other Revenue Growth Rate (2015-2020)
Figure 65. Global Peptide Therapeutics Drugs Revenue Share by Application (2015-2020)
Figure 66. Global Peptide Therapeutics Drugs Revenue Share by Application in 2019
Figure 67. Global Peptide Therapeutics Drugs Market Share Forecast by Application (2021-2025)
Figure 68. Global Cancer Revenue Growth Rate (2015-2020)
Figure 69. Global Metabolic Disorders Revenue Growth Rate (2015-2020)
Figure 70. Global Central Nervous System Revenue Growth Rate (2015-2020)
Figure 71. Global Other Revenue Growth Rate (2015-2020)
Figure 72. Global Peptide Therapeutics Drugs Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 73. Global Peptide Therapeutics Drugs Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 74. Global Peptide Therapeutics Drugs Revenue Market Share Forecast by Regions (2021-2025)
Figure 75. North America Peptide Therapeutics Drugs Revenue Market Forecast (2021-2025)
Figure 76. Europe Peptide Therapeutics Drugs Revenue Market Forecast (2021-2025)
Figure 77. Asia-Pacific Peptide Therapeutics Drugs Revenue Market Forecast (2021-2025)
Figure 78. South America Peptide Therapeutics Drugs Revenue Market Forecast (2021-2025)
Figure 79. Middle East and Africa Peptide Therapeutics Drugs Revenue Market Forecast (2021-2025)
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
生物学的治療薬の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Biologic Therapeutics Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 5.8% in the forecast period of 2020 to 2025 and will expected to reach USD 414920 million by 2025, from USD 331750 million in 2019. The Biologic…- 頭頸部がん治療薬/治療剤の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Head and Neck Cancer Drugs/Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 4.0% in the forecast period of 2020 to 2025 and will expected to reach USD 1466.9 million by 2025, from USD 1255.8 million in 2019. …
- 線維筋痛症治療薬の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The Fibromyalgia Therapeutics Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain opt…
- ペプチド＆ヘパリンの世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Peptide and Heparin market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Peptide and Heparin marke…
- コラーゲンペプチド・ゼラチンの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Collagen Peptide and Gelatin market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 5.1% in the forecast period of 2020 to 2025 and will expected to reach USD 6485.7 million by 2025, from USD 5315.4 million in 2019. The Collage…